Incomplete team staffing, burnout, and work intentions among US physicians
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Jul-2025 06:10 ET (29-Jul-2025 10:10 GMT/UTC)
While it may seem intuitive that people would die without life-saving medications, Penn and Harvard researchers have connected losing a federally funded prescription drug assistance program and an increase in mortality. The program, called the Medicare Part D Low-Income Subsidy (LIS), helps 14.2 million low-income Medicare beneficiaries, many of whom are older Americans, afford their medications. Nationally,12.5 million people who are eligible for and enrolled in both Medicare and Medicaid (“dual eligibles”) automatically qualify for the LIS, which is worth about $6,200/year.
A small cluster of cells deep within our brains, called the locus coeruleus, affects how awake and attentive we are, how we respond to stress, how we cope with anxiety and fear, and how we create memories and learn.This blue spot is also involved in a range of neurological and neuropsychiatric conditions such as anxiety and depression, post-traumatic stress disorder and Alzheimer’s diseases. A new study in mice shows that a small group of cells next to the locus coeruleus, called peri-LC neurons, appear to play a key role in regulating and fine-tuning its information-processing.The findings help explain how we respond appropriately to different challenges, Besides advancing understanding of how our brains regulate arousal, attention and our reactions to distress, the findings open the possibility of new ways to treat neurological and neuropsychiatric disorders, including opioid drug withdrawal symptoms.
As the U.S. continues to face complex public health challenges, a new paper published by a researcher at Columbia University Mailman School of Public Health calls for a redefinition of the public health workforce—one that goes beyond traditional boundaries and acknowledges the growing number of professionals outside government agencies who contribute to public health.
Scientists report that daratumumab can assist cancer patients with low physical function to reduce risk of disease progression and live longer.